Here are four points:
1. By 2024, the market is anticipated to reach $9.9 billion.
2. Both governmental and non-governmental organization initiatives aimed at raising awareness on safe drug delivery are spurring market growth.
3. Last year, North America led the market due to a high approval rate of injectable drugs.
4. Market players include:
• Braun Medical in Bethlehem, Pa.
• Fresenius Kabi in Bad Homburg vor der Höhe, Germany
• Baxter International in Deerfield, Ill.
• Terumo Corp. in Tokyo, Japan
• Novo Nordisk in Bagsværd, Denmark
• Covidien in Dublin, Ireland
• Retractable Technologies in Little Elm, Texas
• Becton, Dickinson and Co. in Franklin Lakes, N.J.
More articles on quality & infection control:
Study: ’32k fewer patients would die every year if male physicians could achieve the same outcomes as female physicians’
Medical devices at risk of denial-of-service attacks — 5 insights
3 new studies reveal various types of brain damage in Zika-infected babies: 4 points
